| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | RATIONALE 302: Randomized, phase 3 study of tislelizumab versus chemotherapy as second-line treatment for advanced unresectable/metastatic esophageal squamous cell carcinoma. |
| Type de publication | Journal Article |
| Year of Publication | 2021 |
| Auteurs | Shen L, Kato K, Kim S-B, Ajani JA, Zhao K, He Z, Yu X, Shu Y, Luo Q, Wang J, Chen Z, Niu Z, Sun JMu, Lin C-Y, Hara H, Pazo-Cid R, Borg C, Li L, Tao A, Van Cutsem E |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 39 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.4012 |
